Homocystynuria
Etiologia i przyczyny

Homocystynuria to autosomalnie recesywne zaburzenie metaboliczne charakteryzujące się podwyższonym stężeniem homocysteiny i metioniny we krwi oraz moczu, wynikające głównie z mutacji w genie CBS (chromosom 21q22.3), prowadzących do niedoboru enzymu cystathionine beta-synthase. Patogeneza obejmuje zaburzenia szlaków transsulfuracji (typ 1) i remetylacji homocysteiny (typy 2 i 3), z udziałem mutacji w genach MTHFR, MTR, MTRR, MMADHC i HCFC1. Klinicznie wyróżnia się fenotypy wrażliwe i niewrażliwe na pirydoksynę (witaminę B6). Diagnostyka opiera się na oznaczeniu stężenia homocysteiny całkowitej, metioniny i cysteiny w osoczu, a także badaniach genetycznych potwierdzających mutacje. Wartości biochemiczne typowe dla klasycznej homocystynurii to podwyższone stężenia homocysteiny i metioniny, natomiast w defektach remetylacji obserwuje się hiperhomocysteinemię z prawidłowym lub obniżonym poziomem metioniny. Epidemiologicznie częstość występowania wynosi około 1:200 000-350 000 żywych urodzeń, z wyższą zapadalnością w populacjach o dużej częstości małżeństw krewniaczych.

Homocystynuria – Etiologia, przyczyny, patogeneza

Homocystynuria to rzadkie, dziedziczne zaburzenie metaboliczne, charakteryzujące się nieprawidłowym metabolizmem aminokwasów siarkowych, prowadzące do podwyższonego stężenia homocysteiny we krwi i moczu. Patogeneza i przyczyny tego schorzenia obejmują zarówno czynniki genetyczne, jak i środowiskowe, które prowadzą do zaburzeń w szlakach metabolicznych homocysteiny.12

Przyczyny genetyczne

Klasyczna homocystynuria, będąca najczęstszą postacią choroby, jest spowodowana mutacjami w genie CBS (cystathionine beta-synthase), zlokalizowanym na chromosomie 21q22.3. Mutacje te prowadzą do niedoboru lub nieprawidłowej funkcji enzymu CBS, który w normalnych warunkach katalizuje konwersję homocysteiny do cystationiny w szlaku transsulfuracji. Niedobór tego enzymu powoduje gromadzenie się homocysteiny oraz metioniny we krwi i moczu.123

Poza klasyczną homocystynurią spowodowaną niedoborem CBS, zidentyfikowano również inne genetyczne przyczyny homocystynurii:12

  • Mutacje w genie MTHFR (methylenetetrahydrofolate reductase), prowadzące do niedoboru enzymu reduktazy metylenotetrahydrofolianowej, która jest niezbędna do remetylacji homocysteiny do metioniny12
  • Mutacje w genach MTR i MTRR, kodujących enzymy uczestniczące w szlaku remetylacji homocysteiny12
  • Mutacje w genie MMADHC, prowadzące do zaburzeń metabolizmu kobalaminy12
  • Mutacje w genie HCFC1, które najczęściej powodują homocystynurię typu cblX z kwasicą metylomalonową1

Homocystynuria jest dziedziczona w sposób autosomalny recesywny, co oznacza, że do rozwoju choroby niezbędne jest odziedziczenie dwóch zmutowanych kopii genu – po jednej od każdego z rodziców. Nosiciele jednej zmutowanej kopii genu zazwyczaj nie wykazują objawów choroby.123

Przyczyny niegenentyczne

Poza przyczynami genetycznymi, homocystynuria może również wynikać z czynników niegenetycznych, choć te przypadki są zwykle mniej nasilone. Do najważniejszych przyczyn niegenetycznych należą:12

  • Ciężki niedobór witaminy B6 (pirydoksyny), która jest kofaktorem enzymu CBS12
  • Niedobór witaminy B12 (kobalaminy), niezbędnej w procesie remetylacji homocysteiny do metioniny12
  • Niedobór kwasu foliowego (witaminy B9), uczestniczącego w procesie remetylacji12
  • Czynniki stylu życia jak palenie papierosów, spożywanie alkoholu i nadmierne spożycie kawy12
  • Przyjmowanie niektórych leków, takich jak metotreksat, tlenek azotu, fenytoina, karbamazepina czy atorwastatyna12

Patogeneza homocystynurii

Patogeneza homocystynurii związana jest z zaburzeniem metabolizmu metioniny, niezbędnego aminokwasu zawierającego siarkę. W prawidłowych warunkach metionina ulega przekształceniu do homocysteiny, która następnie może być metabolizowana na dwa sposoby:12

  • Poprzez remetylację z powrotem do metioniny – proces zależny od witaminy B12 i kwasu foliowego
  • Poprzez transsulfurację do cystationiny, a następnie do cysteiny – proces katalizowany przez enzym CBS zależny od witaminy B6

W zależności od rodzaju homocystynurii, zaburzeniu ulega jeden z tych szlaków metabolicznych:12

  1. Typ 1 (klasyczna homocystynuria) – spowodowany niedoborem enzymu CBS, co prowadzi do zaburzenia szlaku transsulfuracji. Skutkuje to podwyższonym stężeniem homocysteiny i metioniny we krwi.
  2. Typ 2 – wynikający z defektu syntezy metylokobalaminy, co zaburza proces remetylacji homocysteiny do metioniny.
  3. Typ 3 – spowodowany nieprawidłowościami w enzymatycznej funkcji reduktazy metylenotetrahydrofolianowej (MTHFR), co również zaburza remetylację homocysteiny.

Mechanizmy patofizjologiczne prowadzące do objawów klinicznych homocystynurii nie zostały w pełni wyjaśnione, jednak uważa się, że gromadzenie się homocysteiny odgrywa kluczową rolę w rozwoju powikłań naczyniowych i zakrzepowo-zatorowych.12

Wysoki poziom homocysteiny prowadzi do uszkodzenia śródbłonka naczyniowego, aktywacji płytek krwi i zwiększonej krzepliwości, co sprzyja powstawaniu zakrzepów. Powikłania zakrzepowo-zatorowe są główną przyczyną zgonów u pacjentów z klasyczną homocystynurią.12

Badania sugerują również, że homocysteina wywiera toksyczny wpływ na tkankę łączną, co prawdopodobnie przyczynia się do rozwoju objawów ocznych i kostnych, charakterystycznych dla homocystynurii. Ponadto niedobór cysteiny, będący konsekwencją zaburzenia szlaku transsulfuracji, może również odgrywać rolę w rozwoju nieprawidłowości tkanki łącznej, w tym przemieszczenia soczewki.12

Fenotypy kliniczne

W klasycznej homocystynurii wyróżnia się dwa główne fenotypy kliniczne:12

  • Postać wrażliwa na pirydoksynę (witaminę B6) – zazwyczaj łagodniejsza, występująca u około 50% pacjentów. U tych osób podawanie dużych dawek witaminy B6 może znacząco obniżyć poziom homocysteiny.
  • Postać niewrażliwa na pirydoksynę – cięższa postać choroby, w której suplementacja witaminą B6 nie przynosi zadowalających efektów terapeutycznych.

Defekty remetylacji, spowodowane niedoborem MTHFR lub zaburzeniami metabolizmu kobalaminy, charakteryzują się innym profilem biochemicznym niż klasyczna homocystynuria. W tych przypadkach obserwuje się podwyższone stężenie homocysteiny, ale prawidłowe lub obniżone stężenie metioniny, w przeciwieństwie do klasycznej homocystynurii, gdzie stężenie metioniny jest podwyższone.12

Korelacje genotypowo-fenotypowe

W przypadku homocystynurii zidentyfikowano ponad 320 różnych alleli chorobotwórczych i ponad 100 mutacji w genie CBS. Najczęstszymi mutacjami są G307S i I278T. Mutacja I278T jest zwykle związana z fenotypem wrażliwym na pirydoksynę, podczas gdy mutacja G307S prowadzi do wariantu niewrażliwego na leczenie pirydoksyną.12

Pacjenci z homocystynurią wykazują znaczną heterogenność kliniczną, nawet wśród osób z tym samym genotypem w obrębie jednej rodziny, co sugeruje wpływ dodatkowych czynników genetycznych i środowiskowych na ekspresję fenotypową choroby.1

Badania epidemiologiczne wykazały, że częstość występowania homocystynurii wynosi około 1 na 200 000-350 000 żywych urodzeń, choć w niektórych populacjach, jak na przykład w Katarze, częstość ta może być znacznie wyższa.12

Badania przesiewowe i diagnostyka

Programy badań przesiewowych noworodków w kierunku homocystynurii są obecnie dostępne w wielu krajach, w tym w Czechach, Niemczech, Hiszpanii, Wielkiej Brytanii, Irlandii, a także w niektórych stanach USA, Katarze, Japonii, Korei i Australii.12

Jednak nadal u znacznej części pacjentów diagnoza stawiana jest dopiero po wystąpieniu objawów klinicznych. Według badań ankietowych, u połowy pacjentów diagnozowanych klinicznie rozpoznanie ustalono w ciągu roku od wystąpienia pierwszych objawów, jednak u 12,5% pacjentów opóźnienie diagnostyczne wynosiło ponad 15 lat.1

Badania przesiewowe noworodków, oparte na oznaczeniu stężenia metioniny we krwi, są szczególnie przydatne w przypadku chorób poddających się leczeniu, których diagnoza kliniczna jest często opóźniona, jak homocystynuria.12

W diagnostyce homocystynurii kluczowe znaczenie ma oznaczenie stężenia homocysteiny całkowitej w osoczu, a także badanie profilu aminokwasów, w tym metioniny i cysteiny. W przypadku podejrzenia zaburzeń remetylacji pomocne może być oznaczenie kwasu metylomalonowego w osoczu lub moczu.12

Rozpoznanie może być potwierdzone badaniami genetycznymi, ukierunkowanymi na wykrycie mutacji w genach związanych z homocystynurią, co ma również znaczenie dla poradnictwa genetycznego.12

Wpływ homocysteiny na organizm

Homocysteina i jej pochodne wywierają wielokierunkowy, szkodliwy wpływ na różne tkanki i układy organizmu. Badacze wciąż pracują nad pełnym wyjaśnieniem mechanizmów patofizjologicznych leżących u podstaw objawów klinicznych homocystynurii, jednak zidentyfikowano kilka kluczowych procesów.12

Wpływ na układ sercowo-naczyniowy

Jednym z najbardziej charakterystycznych i niebezpiecznych następstw podwyższonego stężenia homocysteiny jest zwiększone ryzyko powikłań zakrzepowo-zatorowych. Homocysteina wywiera toksyczny wpływ na śródbłonek naczyniowy, powodując jego uszkodzenie i dysfunkcję. Prowadzi to do zwiększonej adhezji i agregacji płytek krwi, aktywacji kaskady krzepnięcia oraz zmniejszonej fibrynolizy, co sprzyja powstawaniu zakrzepów.12

Powikłania zakrzepowo-zatorowe mogą manifestować się jako:12

  • Zakrzepica żył głębokich
  • Zatorowość płucna
  • Udar mózgu
  • Niedrożność tętnic obwodowych
  • Zawał mięśnia sercowego

Ryzyko wystąpienia incydentu naczyniowego u pacjentów z klasyczną homocystynurią wynosi 25% przed 16. rokiem życia i 50% do 30. roku życia. Powikłania zakrzepowo-zatorowe stanowią najczęstszą przyczynę zgonów w tej grupie pacjentów.1

Hiperhomocysteinemia jest również dodatnio związana z niewydolnością serca, stanowiąc marker prognostyczny długoterminowych zdarzeń sercowych.1

Wpływ na układ nerwowy

Podwyższone stężenie homocysteiny wywiera niekorzystny wpływ na układ nerwowy, co może wynikać zarówno z bezpośredniego działania neurotoksycznego, jak i z powikłań naczyniowych w obrębie mózgu. W klasycznej homocystynurii obserwuje się upośledzenie funkcji poznawczych o różnym nasileniu, od łagodnych trudności w uczeniu się po znaczną niepełnosprawność intelektualną.12

Hiperhomocysteinemia jest również czynnikiem ryzyka rozwoju choroby Alzheimera i innych form otępienia. Wysoki poziom homocysteiny we krwi może prowokować chorobę Alzheimera i działać jako modyfikowalny czynnik ryzyka dysfunkcji poznawczej.12

W defektach remetylacji, szczególnie w ciężkim niedoborze MTHFR, objawy neurologiczne są dominujące, prawdopodobnie z powodu zmniejszonej dostępności metylo-THF i metioniny, powodujących zmniejszoną metylację mózgową, co sugerują zmniejszone poziomy SAM w płynie mózgowo-rdzeniowym.1

Wpływ na narząd wzroku

Jednym z najbardziej charakterystycznych objawów klasycznej homocystynurii jest przemieszczenie soczewki (ectopia lentis), które występuje u większości nieleczonych pacjentów. Patogeneza tego zaburzenia wiąże się prawdopodobnie z nieprawidłową strukturą i funkcją włókien zresztowych soczewki, co prowadzi do osłabienia jej zawieszenia.12

Dokładne mechanizmy leżące u podstaw ocznych następstw hiperhomocysteinemii pozostają nie w pełni wyjaśnione. Badania sugerują, że podwyższony poziom homocysteiny może zmniejszać transport folianów do fotoreceptorów, co wpływa na wewnątrzkomórkowe procesy anaboliczne i zaburza funkcję fotoreceptorów stożkowych. Hiperhomocysteinemia może również prowadzić do uszkodzenia mikronaczyniowego siatkówki oraz wywierać toksyczny wpływ na neurony warstwy komórek zwojowych.1

Warto zauważyć, że w zaburzeniach remetylacji pacjenci zazwyczaj nie wykazują przemieszczenia soczewki, co sugeruje odmienny mechanizm patogenetyczny w porównaniu z klasyczną homocystynurią.1

Wpływ na układ kostny

U pacjentów z klasyczną homocystynurią obserwuje się charakterystyczne zmiany w układzie kostnym, przypominające zespół Marfana, takie jak wysoki wzrost, długie kończyny, skolioza i klatka piersiowa szewska. Patogeneza tych zaburzeń wiąże się prawdopodobnie z nieprawidłową strukturą i funkcją tkanki łącznej, wynikającą z toksycznego działania homocysteiny.12

Dokładny mechanizm nadmiernego wzrostu u pacjentów z homocystynurią pozostaje kontrowersyjny. Badania sugerują bezpośredni wpływ homocysteiny na proliferację komórek, co może przyczyniać się do zwiększonego wzrostu.1

Podobnie jak w przypadku zaburzeń ocznych, pacjenci z defektami remetylacji zazwyczaj nie wykazują zaburzeń kostnych, wysokiego wzrostu i osteoporozy, co wskazuje na odmienny mechanizm patogenetyczny.1

Wpływ na układ krwiotwórczy

Zaburzenia hematologiczne, takie jak niedokrwistość megaloblastyczna, małopłytkowość, neutropenia i zagrażająca życiu mikroangiopatia, są charakterystyczne dla niedoboru cblC, jednej z przyczyn homocystynurii.1

Najczęstszą przyczyną wysokiego poziomu homocysteiny jest niedobór witaminy B12 lub kwasu foliowego, co często jest podejrzewane, gdy morfologia krwi ujawnia niedokrwistość makrocytową.1

Czynniki ryzyka i epidemiologia

Homocystynuria występuje we wszystkich grupach etnicznych na całym świecie, aczkolwiek z różną częstością w zależności od populacji. Szacuje się, że globalna częstość występowania klasycznej homocystynurii wynosi około 1:200 000-350 000 żywych urodzeń.12

Choroba występuje częściej u osób pochodzenia irlandzkiego oraz u osób białych z regionu Nowej Anglii w Stanach Zjednoczonych. W Katarze i innych krajach Bliskiego Wschodu, gdzie małżeństwa między krewnymi są częstsze, obserwuje się wyższą częstość występowania homocystynurii.1

Czynniki genetyczne i nosicielstwo

Głównym czynnikiem ryzyka homocystynurii jest nosicielstwo zmutowanego genu. Ze względu na autosomalny recesywny sposób dziedziczenia, choroba rozwija się tylko u osób, które odziedziczyły dwie kopie zmutowanego genu – po jednej od każdego rodzica.12

Rodzice dziecka z homocystynurią są zazwyczaj nosicielami jednej kopii zmutowanego genu i nie wykazują objawów choroby. Gdy oboje rodzice są nosicielami, ryzyko wystąpienia homocystynurii u ich dziecka wynosi 25% w każdej ciąży.12

Badania genetyczne mogą być przydatne w identyfikacji nosicieli mutacji, co ma znaczenie dla poradnictwa genetycznego i planowania rodziny u osób z obciążonym wywiadem rodzinnym.12

Czynniki środowiskowe i styl życia

Poza uwarunkowaniami genetycznymi, na poziom homocysteiny we krwi mogą wpływać różne czynniki środowiskowe i związane ze stylem życia:12

  • Palenie papierosów
  • Spożywanie alkoholu
  • Nadmierne spożycie kawy
  • Dieta uboga w witaminy z grupy B (B6, B9, B12)
  • Zaawansowany wiek

Choroby współistniejące

Podwyższony poziom homocysteiny we krwi może być również związany z innymi schorzeniami, takimi jak:1

  • Niedoczynność tarczycy
  • Cukrzyca
  • Hipercholesterolemia
  • Nadciśnienie tętnicze
  • Niewydolność nerek

Leki wpływające na poziom homocysteiny

Niektóre leki mogą wpływać na metabolizm homocysteiny, prowadząc do jej podwyższenia we krwi. Do leków tych należą:12

  • Metotreksat
  • Tlenek azotu
  • Fenytoina
  • Karbamazepina
  • Inhibitory pompy protonowej
  • Atorwastatyna i inne statyny

Podawanie azarybiny również powoduje homocystynurię, poprzez mechanizm, który nie został jeszcze wyjaśniony.1

Mechanizmy interakcji metabolicznych

Homocysteina zajmuje kluczową pozycję na skrzyżowaniu kilku ważnych szlaków metabolicznych, co tłumaczy różnorodność objawów i powikłań występujących w homocystynurii. Aby lepiej zrozumieć patofizjologię tego schorzenia, warto przyjrzeć się interakcjom między tymi szlakami.12

Szlak transsulfuracji

Szlak transsulfuracji jest główną drogą katabolizmu homocysteiny, prowadzącą do syntezy cysteiny. Kluczowym enzymem w tym szlaku jest cystationina beta-syntaza (CBS), która katalizuje kondensację homocysteiny z seryną, tworząc cystationinę. Reakcja ta wymaga pirydoksalo-5-fosforanu (aktywnej formy witaminy B6) jako kofaktora.12

W klasycznej homocystynurii, spowodowanej niedoborem CBS, szlak ten jest zaburzony, co prowadzi do:1

  • Akumulacji homocysteiny i metioniny w tkankach
  • Braku cystationiny
  • Niskiego poziomu cysteiny

Niedobór cysteiny, będący konsekwencją zaburzenia szlaku transsulfuracji, może przyczyniać się do rozwoju nieprawidłowości tkanki łącznej obserwowanych w homocystynurii.1

Szlak remetylacji

Szlak remetylacji umożliwia przekształcenie homocysteiny z powrotem do metioniny, co stanowi alternatywną drogę metabolizmu homocysteiny. Proces ten wymaga:12

  • Metylkobalaminy (pochodnej witaminy B12) jako kofaktora dla syntazy metioniny
  • 5-metylotetrahydrofolianu jako donora grupy metylowej, który jest produktem działania reduktazy metylenotetrahydrofolianowej (MTHFR)

Zaburzenia remetylacji mogą być spowodowane:12

  • Niedoborem MTHFR
  • Zaburzeniami metabolizmu kobalaminy, prowadzącymi bezpośrednio lub pośrednio do upośledzenia aktywności syntazy metioniny
  • Dziedzicznymi zaburzeniami wchłaniania i transportu kobalaminy, w tym mutacjami w czynnikach wewnętrznym żołądkowym, podjednostkach receptora cubam – kubilinie i amnionless (zespół Imerslund-Gräsbeck) oraz TC-2

Defekty remetylacji prowadzą do hiperhomocysteinemii, której towarzyszy niski lub prawidłowo-niski poziom metioniny, w przeciwieństwie do klasycznej homocystynurii, gdzie poziom metioniny jest podwyższony.1

Interakcje z witaminami

Metabolizm homocysteiny jest ściśle związany z kilkoma witaminami, które pełnią funkcję kofaktorów w kluczowych reakcjach enzymatycznych:12

  • Witamina B6 (pirydoksyna) – jest prekursorem pirydoksalo-5-fosforanu, kofaktora enzymu CBS w szlaku transsulfuracji. Około 50% pacjentów z homocystynurią spowodowaną niedoborem CBS reaguje częściowo lub całkowicie na wysokie dawki pirydoksyny.
  • Witamina B12 (kobalamina) – jest prekursorem metylkobalaminy, kofaktora syntazy metioniny w szlaku remetylacji. Niedobór witaminy B12 może prowadzić do zaburzeń remetylacji homocysteiny.
  • Witamina B9 (kwas foliowy) – uczestniczy w syntezie 5-metylotetrahydrofolianu, który jest donorem grupy metylowej w procesie remetylacji homocysteiny do metioniny.

U pacjentów z niedoborem CBS w momencie diagnozy często stwierdza się niedobór kwasu foliowego, prawdopodobnie z powodu hamowania MTHFR, co prowadzi do zmniejszenia 5MTHF, formy krążącej kwasu foliowego. W niedoborze MTHFR kwas foliowy jest znacznie zmniejszony, podczas gdy w defekcie cblC wszystkie foliany gromadzą się jako 5MTHF, co prowadzi do czynnościowego niedoboru folianów komórkowych.1

Interakcje te tłumaczą, dlaczego suplementacja witaminami z grupy B może być skuteczna w leczeniu niektórych postaci homocystynurii, a także dlaczego niedobory tych witamin mogą przyczyniać się do hiperhomocysteinemii.12

Stres oksydacyjny

Podwyższony poziom homocysteiny może indukować stres oksydacyjny poprzez generowanie reaktywnych form tlenu, co prowadzi do uszkodzenia śródbłonka naczyniowego i innych tkanek. Mechanizm ten może przyczyniać się do rozwoju powikłań naczyniowych i neurologicznych obserwowanych w homocystynurii.1

Wpływ na stężenie SAM

S-adenozylometionina (SAM) jest głównym donorem grup metylowych w organizmie, uczestniczącym w licznych reakcjach metylacji DNA, białek i lipidów. W niedoborze MTHFR obserwuje się zmniejszone stężenie SAM w płynie mózgowo-rdzeniowym, co sugeruje zmniejszoną metylację mózgową i może tłumaczyć dominujące objawy neurologiczne w tej postaci homocystynurii.1

Zaburzenia metylacji mogą prowadzić do szeregu nieprawidłowości rozwojowych i funkcjonalnych, szczególnie w układzie nerwowym, co tłumaczy różnorodność objawów neurologicznych obserwowanych w homocystynurii.1

Rola badań genetycznych

Badania genetyczne odgrywają kluczową rolę w diagnostyce, poradnictwie genetycznym i leczeniu homocystynurii. Identyfikacja specyficznych mutacji genetycznych może pomóc w ustaleniu dokładnej przyczyny choroby, przewidywaniu jej przebiegu klinicznego oraz optymalizacji strategii terapeutycznych.12

Diagnostyka genetyczna

Analiza genetyczna może być przeprowadzona w celu potwierdzenia klinicznego podejrzenia homocystynurii, szczególnie w przypadkach o niejednoznacznym obrazie biochemicznym. Badania te mogą obejmować:12

  • Sekwencjonowanie genów związanych z homocystynurią (CBS, MTHFR, MTR, MTRR, MMADHC i innych)
  • Analizę dużych delecji lub duplikacji
  • Badania funkcjonalne ekspresji genów

Identyfikacja specyficznych mutacji genetycznych może mieć również znaczenie prognostyczne. Na przykład, mutacja I278T w genie CBS jest zwykle związana z fenotypem wrażliwym na pirydoksynę, podczas gdy mutacja G307S prowadzi do wariantu niewrażliwego na leczenie pirydoksyną.1

Poradnictwo genetyczne

Poradnictwo genetyczne jest zalecane dla osób z obciążonym wywiadem rodzinnym w kierunku homocystynurii, które planują założenie rodziny. Na podstawie analizy genetycznej można określić ryzyko przekazania choroby potomstwu oraz omówić dostępne opcje profilaktyczne.12

W przypadku par, w których oboje partnerzy są nosicielami mutacji, dostępne są różne opcje, w tym:12

  • Diagnostyka prenatalna, obejmująca badanie komórek owodniowych lub kosmków kosmówki pod kątem aktywności cystationiny beta-syntazy lub specyficznych mutacji genetycznych
  • Diagnostyka preimplantacyjna, umożliwiająca selekcję zarodków bez mutacji przed ich implantacją w macicy
  • Dawstwo gamet

Badania przesiewowe noworodków

Programy badań przesiewowych noworodków w kierunku homocystynurii są obecnie dostępne w wielu krajach. Tradycyjnie badania te opierały się na oznaczeniu stężenia metioniny we krwi, co umożliwia wykrycie klasycznej homocystynurii (spowodowanej niedoborem CBS), w której stężenie metioniny jest podwyższone.12

Należy jednak zauważyć, że tradycyjne badania przesiewowe oparte na oznaczeniu metioniny mogą nie wykrywać zaburzeń remetylacji (spowodowanych niedoborem MTHFR lub zaburzeniami metabolizmu kobalaminy), w których stężenie metioniny jest prawidłowe lub obniżone.1

Nowsze metody badań przesiewowych, oparte na spektrometrii mas, umożliwiają jednoczesne oznaczenie wielu metabolitów, w tym homocysteiny, co może zwiększyć czułość i swoistość badań przesiewowych.1

Wyniki badania ankietowego sugerują, że pacjenci wykryci w badaniach przesiewowych noworodków wykazują większe zadowolenie z procedury diagnostycznej oraz leczenia i opieki medycznej niż ci wykryci klinicznie.1

Badania rodzinne

Po zdiagnozowaniu homocystynurii u indeksa, zaleca się przeprowadzenie badań przesiewowych u członków rodziny, szczególnie u rodzeństwa, w celu wykrycia innych przypadków choroby, które mogą być bezobjawowe lub skąpoobjawowe.12

Badania nosicielstwa mogą być również oferowane dorosłym członkom rodziny, którzy planują założenie rodziny, w celu oceny ryzyka przekazania choroby potomstwu.1

Znaczenie wczesnej diagnostyki

Wczesna diagnostyka homocystynurii ma kluczowe znaczenie dla zapobiegania poważnym powikłaniom choroby. Badania przesiewowe noworodków, umożliwiające wczesne wykrycie i leczenie homocystynurii, mogą znacząco poprawić rokowanie i jakość życia pacjentów.12

Niestety, w wielu przypadkach diagnoza jest stawiana dopiero po wystąpieniu objawów klinicznych, często z wieloletnim opóźnieniem. Według badań ankietowych, u połowy pacjentów diagnozowanych klinicznie rozpoznanie ustalono w ciągu roku od wystąpienia pierwszych objawów, jednak u 12,5% pacjentów opóźnienie diagnostyczne wynosiło ponad 15 lat.1

Wczesne rozpoczęcie leczenia, dostosowanego do specyficznej przyczyny homocystynurii, może zapobiec lub złagodzić wiele powikłań choroby, w tym zaburzenia neurologiczne, powikłania zakrzepowo-zatorowe oraz zmiany w narządzie wzroku i układzie kostnym.12

Badanie ankietowe wykazało, że większość pacjentów uważa, że diagnoza została przekazana w zadowalający sposób, jednak ankieta pokazuje, że nadal istnieje pole do poprawy umiejętności komunikacyjnych lekarzy i dostarczania większej ilości informacji o chorobie.1

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Homocystinuria (HCU): Symptoms, Causes & Treatment
    https://my.clevelandclinic.org/health/diseases/25160-homocystinuria
    Homocystinuria is a genetic disorder that causes a buildup of homocysteine in your blood and urine. […] With homocystinuria, your body lacks an enzyme that it needs to metabolize homocysteine properly and keep it within a normal range. […] Genetic changes (mutations) in many different genes cause most types of homocystinuria. A mutation in the CBS gene causes the most common type of homocystinuria. […] Mutations in the MTHFR, MTR, MTRR and MMADHC genes can also cause homocystinuria. […] Homocystinuria can also occur due to non-genetic reasons. A severe lack of vitamin B6, vitamin B9 (folate) or vitamin B12 may cause the condition.
  • #1 Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency – GeneReviews® – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK1524/
    Homocystinuria caused by cystathionine -synthase (CBS) deficiency is characterized by involvement of the eye (ectopia lentis and/or severe myopia), skeletal system (excessive height, long limbs, scoliosis, and pectus excavatum), vascular system (thromboembolism), and CNS (developmental delay/intellectual disability). […] Classic homocystinuria is caused by deficiency of cystathionine -synthase (CBS), a pyridoxine (vitamin B6)-dependent enzyme. […] Homocystinuria is inherited in an autosomal recessive manner. […] The two phenotypic variants of classic homocystinuria are B6-responsive and B6-non-responsive homocystinuria. B6-responsive homocystinuria is typically (but not always) milder than the non-responsive variant. […] „Homocystinuria” was named for excess homocystine in the urine, though now it is primarily detected by increased total homocysteine in plasma. Homocystinuria may be caused by genetically determined deficient activity of cystathionine -synthase (CBS), or a variety of genetic problems that ultimately interfere with conversion of homocysteine to methionine. […] Non-genetically determined severe dietary lack of cobalamin (vitamin B12 deficiency) may also cause „homocystinuria”.
  • #1 SciELO Brazil – Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they Have in Common? Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they Have in Common?
    https://www.scielo.br/j/jiems/a/5KjZr63wC5Md7t3ZW5SpBhn/
    Severe methylenetetrahydrofolate reductase (MTHFR) deficiency is inherited as an autosomal recessive metabolic disorder of folate metabolism caused by mutations in the MTHFR gene on chromosome 1p36.3. […] Homocystinuria due to MTHFR deficiency (OMIM ID: 236250) was first described in 1972 by Mudd et al. in a 16-year-old boy with muscle weakness, seizures and abnormal encephalographic signs, a 17-year-old girl with mental degradation and schizophrenia and her sister. […] Severe MTHFR deficiency is biochemically characterized by hyperhomocysteinemia, homocystinuria, increased cystathionine, and low or low-normal Met, in contrast with CBS deficiency, which presents with elevated Met. […] In summary, MTHFR deficiency is a severe disease primarily affecting the CNS, likely due to the reduced availability of methyl-THF and Met, causing reduced cerebral methylation as suggested by decreased SAM levels in CSF.
  • #1 Homocystinuria: Causes, Symptoms & Diagnosis
    https://www.healthline.com/health/homocystinuria
    Homocystinuria is an inherited disorder that keeps the body from processing the essential amino acid methionine. […] Certain genetic mutations present at birth cause this disease. More than 150 mutations that cause homocystinuria have been found in the gene cystathionine beta-synthase, which is also known as the CBS gene. […] In rare cases, mutations in other genes like MTHFR, MTR, or MTRR cause the disorder. Homocystinuria is an autosomal recessive trait. This means that for a child to have the signs or symptoms of this condition, they would need to inherit the mutated gene from both parents.
  • #1 Methylmalonic acidemia with homocystinuria: MedlinePlus GeneticsLock
    https://medlineplus.gov/genetics/condition/methylmalonic-acidemia-with-homocystinuria/
    Methylmalonic acidemia with homocystinuria can be caused by variants (also known as mutations) in one of several genes, including MMACHC, MMADHC, LMBRD1, and ABCD4. Variants in these genes account for the different types of the disorder: cblC, cblD, cblF, and cblJ, respectively. Another type, called epi-cblC, is caused by variants in the PRDX1 gene, usually in combination with an MMACHC gene variant. […] Variants in the HCFC1 gene are the most common cause of a condition called methylmalonic acidemia with homocystinuria, cblX type. This gene provides instructions for making a protein that helps regulate the activity of other genes, including the MMACHC gene. Variants in the HCFC1 gene (and, less commonly, other related genes) likely disrupt the normal activity of the MMACHC gene, impairing vitamin B12 processing and leading to methylmalonic acidemia or homocystinuria. […] Variants in other genes involved in vitamin B12 processing can cause related conditions. Variants that impair only AdoCbl production lead to methylmalonic acidemia, and variants that impair only MeCbl production cause homocystinuria.
  • #1 Homocystinuria
    https://www.nhs.uk/conditions/homocystinuria/
    Homocystinuria (HCU) is a rare but potentially serious inherited condition. […] The genetic cause (mutation) responsible for HCU is passed on by parents, who usually don’t have any symptoms of the condition. […] The way this mutation is passed on is known as autosomal recessive inheritance. This means a baby needs to receive two copies of the mutated gene to develop the condition one from their mother and one from their father. […] Although it’s not possible to prevent HCU, it’s important to let your midwife and doctor know if you have a family history of the condition.
  • #1 Homocystinuria – EyeWiki
    https://eyewiki.org/Homocystinuria
    Homocystinuria is an autosomal recessive inborn error of amino acid metabolism that results in inability to break down homocysteine to cystathionine due to deficiency in the enzyme cystathionine beta-synthase. […] The main and most prevalent cause of acquired homocystinuria involves enzyme and cofactor dysfunctions involving defects in remethylation and transsulfuration. […] Non-genetic hyperhomocysteinemia can be caused by lifestyle factors like cigarette smoking, alcohol consumption, and coffee consumption in addition to medications like methotrexate, nitrous oxide, phenytoin, and carbamazepine. […] Hyperhomocysteinemia is also positively associated with congestive heart failure, serving as a prognostic marker for long-term cardiac events, but there still lacks a clear disease mechanism.
  • #1 Methionine Metabolism Disorders – Pediatrics – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pediatrics/inherited-disorders-of-metabolism/methionine-metabolism-disorders
    Homocysteine is an intermediate in methionine metabolism; it is either remethylated to regenerate methionine or combined with serine in a series of transsulfuration reactions to form cystathionine and then cysteine. […] Various defects in remethylation or transsulfuration can cause homocysteine to accumulate, resulting in disease. […] This disorder is caused by an autosomal recessive deficiency of cystathionine beta-synthase, which catalyzes cystathionine formation from homocysteine and serine. […] Homocysteine accumulates and dimerizes to form the disulfide homocystine, which is excreted in the urine. […] Because remethylation is intact, some of the additional homocysteine is converted to methionine, which accumulates in the blood. […] Excess homocysteine predisposes to thrombosis and has adverse effects on connective tissue (perhaps involving fibrillin), particularly the eyes and skeleton; adverse neurologic effects may be due to thrombosis or a direct effect.
  • #1 Homocystinuria
    https://webeye.ophth.uiowa.edu/eyeforum/cases/269-Homocystinuria.htm
    Homocystinuria, or accumulation of homocysteine in the blood and urine, is due to an inborn error in methionine metabolism that is commonly inherited in an autosomal recessive fashion. The prevalence of all types of homocystinuria is estimated to be 1: 344,000. There are different types of homocystinuria with the most common type caused by a deficiency in the enzyme cystathionine beta-synthase, which occurs in about 1:50,000 births. This type of homocystinuria is usually detected on newborn screening tests. […] To better describe the pathophysiology of homocystinuria, it is separated into three major categories based on the site of the metabolic defect. Type 1 is due to a deficiency in cystathionine beta-synthase, which converts homocysteine to cystathionine. Type 2 is due to defective methylcobalamin synthesis, which helps to convert homocysteine to methionine. Type 3 is due to an abnormality in methylene tetrahydrofolate reductase, which also helps to convert homocysteine to methionine.
  • #1 Homocystinuria due to cystathionine beta-synthase deficiency | MedLink Neurology
    https://www.medlink.com/articles/homocystinuria-due-to-cystathionine-beta-synthase-deficiency
    In addition to genetic etiologies, homocystinuria can also be caused by acquired forms of secondary to severe cobalamin (B12) deficiency. […] Homocystinuria is an autosomal recessive inherited disorder due to deficiency of cystathionine beta-synthase (EC 4.2.1.22, McKusick 236200). […] More than 320 individual homocystinuric alleles have been studied, and 100 mutations were detected. […] Deficiency of cystathionine beta-synthase leads to tissue accumulation of methionine, homocysteine, and their S-adenosyl derivatives, with lack of cystathionine and low levels of cysteine. […] The pathophysiology of cystathionine beta-synthase deficiency has not yet been completely elucidated, but accumulation of homocysteine probably plays a major role in determining some of the most relevant clinical manifestations, including generalized vascular damage and thromboembolic complications.
  • #1
    https://www.omim.org/entry/236200
    Thromboembolic events are the most common cause of death in patients with classic homocystinuria and can manifest as peripheral vein thrombosis, pulmonary embolism, stroke, peripheral artery occlusion, and myocardial infarction. […] The risk of having a vascular event is 25% before age 16 years and 50% by age 30 years. […] Caused by mutation in the cystathionine beta-synthase gene (CBS, 613381.0001).
  • #1 Orphanet: Homocystinuria due to cystathionine beta-synthase deficiency
    https://www.orpha.net/en/disease/detail/394
    A rare metabolic disease of methionine catabolism characterized by accumulation of methionine and homocysteine with clinical involvement of the eye, skeletal system, vascular system and central nervous system (CNS). […] The disease is caused by mutations in the CBS gene (21q22.3) leading to the accumulation of homocysteine and methionine, which are toxic for the endothelium, and causes neurocognitive impairment. […] Cysteine deficiency probably plays a role in connective tissue abnormalities, including lens dislocation.
  • #1
    https://www.omim.org/entry/236200
    A number sign (#) is used with this entry because homocystinuria with or without response to pyridoxine is caused by homozygous or compound heterozygous mutation in the gene encoding cystathionine beta-synthase (CBS; 613381) on chromosome 21q22. […] Classic homocystinuria is an autosomal recessive metabolic disorder of sulfur metabolism. […] The clinical features of untreated homocystinuria due to CBS deficiency usually manifest in the first or second decade of life and include myopia, ectopia lentis, mental retardation, skeletal anomalies resembling Marfan syndrome (MFS; 154700), and thromboembolic events. […] There are 2 main phenotypes of the classic disorder: a milder pyridoxine (vitamin B6)-responsive form, and a more severe pyridoxine-nonresponsive form. […] Some patients have been reported to have a milder form of homocystinuria, which is characterized by increased plasma homocysteine and increased risk for thrombotic events in young adulthood, but without the other skeletal, ocular, or nervous system manifestations observed in classic homocystinuria.
  • #1 SciELO Brazil – Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they Have in Common? Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they Have in Common?
    https://www.scielo.br/j/jiems/a/5KjZr63wC5Md7t3ZW5SpBhn/
    This paper reviews the clinical and biochemical findings and management of the three most frequent genetic causes of homocystinurias: CBS deficiency or classical homocystinuria (HCU), methylmalonic aciduria with homocystinuria cblC type, and severe MTHFR deficiency. […] These three disorders all present with severe hyperhomocysteinemia, while Met levels are increased in HCU and decreased or normal in cblC and MTHFR deficiency, and methylmalonic acid (MMA) is increased only in cblC. […] In CBS deficient patients at diagnosis folate is often deficient likely due to the inhibition of MTHFR resulting in decreases of 5MTHF, the circulation form of folate. […] In MTHFR deficiency folate is severely deficient, whereas in cblC defect all folates accumulate as 5MTHF resulting in functional cellular folate deficiency.
  • #1 WV DHHR – OMCFH – Newborn Metabolic Screening – Homocystinuria
    https://www.wvdhhr.org/nbms/diseases/Homocystinuria.asp
    The term „homocystinuria” designates a biochemical abnormality, not a specific disease entity. There are many causes of homocystinuria. All affect one of the transsulfation pathways that convert the sulfur atom of methionine into the sulfur atom of cysteine. This pathway is the chief route of disposal of methionine. The most common defect, cystathionine -synthase (CBS) deficiency (OMIM database No. 236200), results in high concentrations of serum methionine. One form of CBS deficiency is responsive to vitamin B6. Other metabolic variants of homocystinuria include defects of vitamin B12 uptake or activation and tetrahydrofolate reductase deficiency (OMIM database No. 236250). […] More than 90 different disease-associated mutations of the CBS gene have been identified. The vast majority of these mutations are „private” mutations that occur in only a single or a very small number of families. The most prevalent mutations are the G307S and I278T mutations. Affected patients vary widely in the extent to which they manifest clinical abnormalities, suggesting considerable genetic heterogeneity. Some of the variability is accounted for by the relative reduction of enzymatic activity. Absent to relatively low residual activity (up to 10%) of CBS has been noted among different families. However, there are reports of individuals with the identical genotype resulting in a different phenotype within the same family.
  • #1 Homocystinuria | PPT
    https://www.slideshare.net/slideshow/homocystinuria-238455286/238455286
    Homocystinuria is a disorder of methionine metabolism, leading to an abnormal accumulation of homocysteine and its metabolites (homocystine, homocysteine-cysteine complex) in blood and urine. […] Homocystinuria is inherited as an autosomal recessive trait. Prevalence of 1 in 200,000 to 350,000 live births has been estimated. […] Homocystinuria Caused by Cystathionine -Synthase Deficiency (Classic Homocystinuria) Methionine is an essential, non-polar -amino acid. Under normal conditions methionine undergoes conversion to homocysteine. […] People suffering from this disease are unable to synthesize CBS, hence leading to an inability to metabolize methionine Due to the absence of CBS enzyme, homocysteine accumulates in the blood serum leading to an increased excretion of homocystine in the urine.
  • #1 Homocystinuria patient and caregiver survey: experiences of diagnosis and patient satisfaction | Orphanet Journal of Rare Diseases | Full Text
    https://ojrd.biomedcentral.com/articles/10.1186/s13023-021-01764-x
    The drug, betaine, can also help to lower homocysteine concentrations. […] Currently, newborn screening programmes targeting at least one of the homocystinurias (most frequently CBS deficiency) are in place in several European countries such as the Czech Republic, Germany, Spain, the UK and Ireland; in several US states; in Qatar, Japan, Korea; and in Australia. […] The diagnosis was made within a year of the first symptoms in half of the clinically ascertained patients in this survey but it was delayed by more than 15 years in 12.5% patients. […] Long diagnostic delays have been found in previous series and the delay has sometimes correlated with age. […] Newborn screening is well suited to treatable diseases whose clinical diagnosis is often delayed. […] Approximately one quarter of the patients in this survey had been detected by newborn screening and reported higher satisfaction with the diagnostic procedure and with treatment and medical care than those detected clinically.
  • #1 Homocystinuria diagnosis and management: it is not all classical | Journal of Clinical Pathology
    https://jcp.bmj.com/content/75/11/744
    In a minority of cases serum B12 and folate results may not reflect whole body deficits and if deficiency is suspected, confirmatory tests are indicated. […] Once secondary causes are excluded, measurement of other amino acids in the HCy metabolic pathway, notably methionine and cystine, with quantitation of MMA in plasma or urine helps to distinguish between the genetic conditions of classical HCU and remethylation defects caused by MTHF reductase (MTHFR) or a disorder of cobalamin metabolism. […] HCU caused by CBS deficiency is the most common condition of hyperhomocystinaemia. […] Thromboembolic tendency increases in direct proportion to the magnitude and duration of HCy elevation. […] The CBS enzyme uses pyridoxal 5-phosphate as a cofactor. Approximately 50% of patients with HCU respond partially or wholly to high-dose pyridoxine (vitamin B6).
  • #1 Homocystinuria | Amino Acid Metabolism Disorder – Causes, Symptoms, Diagnosis and Treatment
    https://www.medindia.net/health/conditions/homocystinuria-amino-acid-metabolism-disorder.htm
    When CBS is deficient, homocysteine accumulates in the tissues along with its precursor amino acid methionine. […] High levels of homocysteine mainly affect supporting connective tissue in different parts of the body. […] The build-up of homocysteine also damages the supporting tissue of the body’s skeleton, and damages the connective tissue in the walls of blood vessels. […] Diagnosis is suspected during clinical examination and based on clinical suspicion diagnosis is confirmed by blood tests, imaging tests and skin biopsy. […] Genetic testing can be done to look for presence of the abnormal gene. […] It is difficult to prevent homocystinuria as this disorder occurs due to genetic mutations. […] Complications of homocystinuria may be prevented by screening of newborns with a blood test around five days within birth to check for the condition so that early treatment can be started.
  • #1 Homocystinuria: MedlinePlus GeneticsLock
    https://medlineplus.gov/genetics/condition/homocystinuria/
    Homocystinuria is an inherited disorder in which the body is unable to process certain building blocks of proteins (amino acids) properly. […] Variants (also called mutations) in the CBS, MTHFR, MTR, MTRR, and MMADHC genes cause homocystinuria. […] Variants in the CBS gene cause classic homocystinuria. […] Rarely, homocystinuria can be caused by variants in several other genes. […] Researchers have not determined how excess homocysteine and related compounds lead to the signs and symptoms of homocystinuria.
  • #1 Homocystinuria – EyeWiki
    https://eyewiki.org/Homocystinuria
    High blood homocysteine level can also provoke Alzheimers disease and acts as a modifiable risk factor for cognitive dysfunction. […] The precise mechanisms for hyperhomocysteinemia related eye disease remain ill defined. […] The primary goal of systemic management is to maintain appropriate levels of homocysteine and to prevent thrombosis. […] Several new therapies are emerging for homocystinuria, including strategies to reduce the amount of methionine absorbed from food, so patients dont have to focus as hard to eat a methionine-restricted diet.
  • #1 Homocystinuria
    https://webeye.ophth.uiowa.edu/eyeforum/cases/269-Homocystinuria.htm
    In this discussion, we will focus on homocystinuria due to methionine synthase deficiency, which is a defect in the methylation pathway of homocysteine. This specific deficiency is characterized by homocystinuria, hyperhomocysteinemia, and hypomethioninemia, without methylmalonic aciduria. Methionine synthase catalyzes the methylation of homocysteine to methionine and can be caused by deficiency in methylene tetrahydrofolate reductase or by deficiency of methylcobalamin cofactors. The patient in this case possesses the cb1G defect, or cobalamin G deficiency, leading to a deficiency in methylcobalamin cofactors. […] There have been few studies that offer theories for the pathophysiologic mechanisms underlying the ocular sequelae of homocystinuria. Poloschek et al. investigated ERG findings in those with methionine synthase deficiency and proposed that increased homocysteine levels decrease the transport of folates to photoreceptors, which in turn decrease intracellular anabolic processes, impacting cone photoreceptor function. They also commented that hyperhomocysteinemia may lead to microvascular damage in the retina, leading to reduced oscillatory potentials. It may also have toxic effects on the neurons of the ganglion cell layer, leading to deformed flash visual evoked potential (VEP) responses.
  • #1 SciELO Brazil – Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they Have in Common? Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they Have in Common?
    https://www.scielo.br/j/jiems/a/5KjZr63wC5Md7t3ZW5SpBhn/abstract/?lang=en
    Genetic homocystinurias are a group of inborn errors of metabolism that result in the massive excretion of homocysteine (Hcy) in the urine due to Hcy accumulation in the body, usually causing neurological and cardiovascular complications. The three most frequent causes are classical homocystinuria [deficiency of cystathionine beta-synthase (CBS)], methylmalonic aciduria with homocystinuria, cblC type (cblC deficiency) and severe methylenetetrahydrofolate reductase (MTHFR) deficiency. […] Moreover, patients with remethylation defects typically do not present ectopia lentis and bone disturbances, tall stature and osteoporosis. […] Whereas hematological alterations, such as megaloblastic anemia, thrombocytopenia neutropenia and life-threatening microangiopathy, are specific findings of cblC deficiency.
  • #1 Influence of Metabolic Control on Growth in Homocystinuria due to Cystathionine B-Synthase Deficiency | Pediatric Research
    https://www.nature.com/articles/pr2001129
    The etiology of the tall stature almost invariably seen in homocystinuric patients is not known. […] It has been difficult to relate this wide variety of symptoms to a deficiency of a single enzyme. […] Both HC and HCA, the sulfonic acid derivative of HC, have been suggested as the cause of the excessive growth. […] These findings have been challenged by other studies that have implicated HC as the agent responsible for growth. […] The cause of the tall stature in homocystinuric patients is controversial. […] An association between increased growth and HC was found in the present study. […] The differences in growth between these two groups of patients cannot be attributed to nutritional factors. […] This suggests that growth is affected only when the HC is greatly increased and, thus, supports the findings of this report. […] A direct effect of HC on cell proliferation has been demonstrated in several studies. […] The present study demonstrates a direct effect of HC on human growth; the exact mode of its action still needs to be determined.
  • #1 Homocystinuria diagnosis and management: it is not all classical | Journal of Clinical Pathology
    https://jcp.bmj.com/content/75/11/744
    Homocystinuria (HCU) refers to a group of inherited disorders of homocysteine metabolism associated with high blood homocysteine concentration, thromboembolic tendency and neurocognitive symptoms. […] The most prevalent inherited disorder of homocysteine metabolism is classical HCU caused by deficiency of the pyridoxine-dependent enzyme, cystathione beta-synthase, which converts homocysteine to cystathionine in the transsulphuration pathway. […] Primary genetic disorders affecting function of CBS (classical HCU) or enzymes involved in remethylation impair metabolism of HCy causing it to rise in plasma from a reference concentration below 15 mol/L to at least 40 mol/L and usually over 100 mol/L. […] The most common causes of a high tHCy relate to underlying vitamin B12 or folate deficiency which is often first suspected when the CBC reveals a macrocytic anaemia.
  • #1 CBS (homocystinemia/cystathionine beta-synthase deficiency) – newbornscreening.info
    https://www.newbornscreening.info/cbs-homocystinemia-cystathionine-beta-synthase-deficiency/
    When both parents are carriers, there is a 25% chance in each pregnancy for the child to have homocystinuria. […] About one in every 200,000 to 300,000 babies in the United States is born with homocystinuria. […] This condition occurs in all ethnic groups around the world. It is found more often in white people from the New England region of the United States. It is also more common in people with Irish ancestry.
  • #1 Homocystinuria: Causes, symptoms, and tests
    https://www.medicalnewstoday.com/articles/318526
    Homocystinuria is a genetic disorder in which the body cannot break down a particular amino acid. […] The disorder passes from parents to children in an autosomal recessive manner, which means that two copies of an irregular gene must be present for it to develop. […] As homocystinuria is genetically autosomal recessive, a child must inherit a copy of the mutated gene for homocystinuria from each parent to develop the condition. […] Parents who carry just one mutated gene may not have any symptoms of homocystinuria. […] According to researchers, the child of parents who both are carriers of the gene has a 25% chance of having homocystinuria. […] The most common form of homocystinuria is called cystathionine beta-synthase (CBS). […] There is no cure for homocystinuria. However, it is possible to manage the condition with dietary restrictions, supplements, and medication. […] The only reason for genetic testing is to give people an idea of their risk of passing on a gene mutation that can lead to homocystinuria.
  • #1 Homocystinuria – Child Neurology Foundation
    https://www.childneurologyfoundation.org/disorder/homocystinuria/
    There are other nongenetic causes of high homocysteine in the blood and urine. These causes are more common than genetic causes. They can have different signs and symptoms. Nongenetic causes can include: […] Vitamin deficiencies, particularly Vitamin B6 or Vitamin B12 deficiencies […] Low thyroid hormone levels […] Diabetes […] High cholesterol […] High blood pressure […] Medications, such as carbamazepine, phenytoin, atorvastatin, methotrexate […] Smoking […] Advanced age.
  • #1 Homocystinuria: pathogenetic mechanisms – PubMed
    https://pubmed.ncbi.nlm.nih.gov/324277/
    Homocystinuria with elevated plasma homocysteine and methionine levels is the result of deficient activity of cystathionine synthetase, the enzyme catalyzing conversion of homocysteine to cystathionine. […] It is inherited as an autosomal recessive trait with a worldwide distribution. […] Low methionine homocystinuria, with deficient remethylation of homocysteine, results from deranged vitamin B(12) metabolism and from deficient 5,10-methylene-tetrahydrofolate reductase. […] Administration of azaribine produces homocystinuria by mechanism not yet elucidated.
  • #1 Homocystinuria | Amino Acid Metabolism Disorder – Causes, Symptoms, Diagnosis and Treatment
    https://www.medindia.net/health/conditions/homocystinuria-amino-acid-metabolism-disorder.htm
    Homocystinuria is a rare inherited genetic disorder. […] When the term homocystinuria is used, it normally refers to classical homocystinuria caused by deficiency of the enzyme cystathionine beta synthase (CBS). […] The defect has been mapped to a gene on chromosome 21. […] In addition to CBS deficiency, there are six other distinct types of homocystinuria due to other enzyme deficiencies including 5,10-methylenetetrahydrofolate reductase deficiency and deficiency of cobalamin in coenzyme synthesis. […] These other deficiencies are severe and reported even more rarely; information is therefore limited and the following discussion will be about classical homocystinuria caused by cystathionine beta synthase (CBS) deficiency. […] The enzyme cystathionine beta synthase (CBS) is necessary for conversion of homocysteine to cysteine.
  • #1 Homocystinuria diagnosis and management: it is not all classical | Journal of Clinical Pathology
    https://jcp.bmj.com/content/75/11/744
    In non-pyridoxine-responsive HCU and some partially responsive patients, target tHCy can only be attained by additionally following a protein restricted diet to limit intake of the essential amino acid, methionine, the precursor to HCy production in the transsulphuration pathway. […] Remethylation defects are caused by MTHFR deficiency (known as 'MTHFR’) and disorders of cobalamin metabolism. […] Cobalamin disorders directly or indirectly impair methionine synthase activity resulting in high tHCy accompanied by a low or low/normal methionine. […] Inherited disorders of cobalamin absorption and transport include mutations in gastric intrinsic factor, the cubam receptor subunits cubilin and amnionless (Imerslund-Grsbeck syndrome) and TC-2.
  • #1 Classical Homocystinuria Publications – HCU Network America
    https://hcunetworkamerica.org/publications/
    Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they have in common? […] Cystathionine Beta-Synthase deficiency in E-HOD registry part 1: pyridoxine responsiveness as determinant of biochemical and clinical phenotype at diagnosis […] Estimated prevalence of moderate to severely elevated total homocysteine levels in the United States: A missed opportunity for diagnosis of homocystinuria? […] Oxidative Stress in Homocystinuria Due to Cystathionine B-Synthase Deficiency: Findings in Patients and in Animal Models […] Potential Pharmacological Chaperones for Cystathionine Beta-Synthase-Deficient Homocystinuria.
  • #1
    https://scite.ai/reports/three-main-causes-of-homocystinuria-ManRGZm
    Individuals with homocystinuria, the most frequent disorder of sulfur metabolism, have many developmental and cognitive difficulties, with a significant number of cases having a learning disability, atherosclerosis, or thromboembolic disease. […] In this form there is a combined deficiency of synthesis of both methylcobalamin (methionine synthase coenzyme) and adenosyl cobalamin (methylmalonyl-CoA mutase coenzyme), with the consequent possibility of homocystinuria and methylmalonic aciduria. A massive homocystinuria with methylmalonic aciduria is characteristic of the combined deficits of the common intracellular metabolism of the B12. Isolated deficiencies of the specific metabolic pathways of adenosylcobalamin and methylcobalamin lead, respectively, to methylmalonic aciduria and homocystinuria.
  • #1 Homocystinuria – UF Health
    https://ufhealth.org/conditions-and-treatments/homocystinuria
    Homocystinuria is inherited in families as an autosomal recessive trait. This means that the child must inherit a non-working copy of the gene from each parent to be seriously affected. […] Genetic counseling is recommended for people with a family history of homocystinuria who want to have children. Prenatal diagnosis of homocystinuria is available. This involves culturing amniotic cells or chorionic villi to test for cystathionine synthase (the enzyme that is missing in homocystinuria). […] If there are known gene defects in the parents or family, samples from chorionic villus sampling or amniocentesis can be used to test for these defects.
  • #1 Homocystinuria, Beta-Synthase Deficiency | Hereditary Ocular Diseases
    https://disorders.eyes.arizona.edu/disorders/homocystinuria-beta-synthase-deficiency
    Classic homocystinuria is an autosomal recessive disorder that results from mutations in the CBS (21q22.3) gene encoding cystathionine beta-synthase. […] Numerous mutations have been identified but among the most common ones are I278T which causes a pyridoxine-responsive disorder, and the G3307S mutation which leads to a variant that is not responsive to pyridoxine treatment. […] Homocystinuria may result from a mutation in in the CBS gene.
  • #1 Homocystinuria Information | Mount Sinai – New York
    https://www.mountsinai.org/health-library/diseases-conditions/homocystinuria
    Homocystinuria is inherited in families as an autosomal recessive trait. This means that the child must inherit a non-working copy of the gene from each parent to be seriously affected. […] Although no cure exists for homocystinuria, vitamin B therapy can help about half of people affected by the condition. […] Genetic counseling is recommended for people with a family history of homocystinuria who want to have children. Prenatal diagnosis of homocystinuria is available. This involves culturing amniotic cells or chorionic villi to test for cystathionine synthase (the enzyme that is missing in homocystinuria).
  • #1 Methionine Metabolism Disorders – Pediatrics – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pediatrics/inherited-disorders-of-metabolism/methionine-metabolism-disorders
    Various defects in the remethylation process can result in homocystinuria. […] Defects include deficiencies of methionine synthase (MS) and MS reductase (MSR), delivery of methylcobalamin and adenosylcobalamin, and deficiency of methylenetetrahydrofolate reductase (MTHFR, which is required to generate the 5-methyltetrahydrofolate needed for the MS reaction). […] Because there is no methionine elevation in these forms of homocystinuria, they are not detected by neonatal screening.
  • #1 Homocystinuria due to cystathionine beta synthase deficiency – Indian Journal of Dermatology, Venereology and Leprology
    https://ijdvl.com/homocystinuria-due-to-cystathionine-beta-synthase-deficiency/
    Two types of homocysteinuria have been reported based on its treatment: one is B6-responsive while the other is not. […] Treatment of B6-responsive patients includes a combination of folic acid, vitamin B12, and pyridoxine, which significantly reduces homocysteine levels. […] Treatment of B6-nonresponsive patients includes lowering of urinary levels of homocysteine and its disulphide derivative, as well as adherence to a methionine-restricted diet. […] The principles of treatment are to correct the biochemical abnormalities, especially to control the elevated plasma homocystine concentration as much as possible and to prevent or at least reduce, the complications of homocysteinuria and to prevent further complications such as thrombosis. […] Treatment with betaine provides an alternate remethylation pathway to convert excess homocysteine into methionine and may help to prevent complications, particularly thrombosis. […] As homocystinuria is a genetic disorder, frequent monitoring of blood homocysteine levels should be done and the duration of treatment should be life long.
  • #1 Homocystinuria patient and caregiver survey: experiences of diagnosis and patient satisfaction | Orphanet Journal of Rare Diseases | Full Text
    https://ojrd.biomedcentral.com/articles/10.1186/s13023-021-01764-x
    The majority of patients thought that the diagnosis had been delivered in a satisfactory way but the survey shows there is still room for physicians to improve their communication skills and to provide more information about the disease. […] Additional problems for patients and carers include the cumbersome procedures for obtaining medications, amino acid supplements and other dietary products and in some countries the high cost of these. […] The survey suggests that treatment of the homocystinurias is not always in line with current recommendations. […] A low-methionine diet is recommended for pyridoxine-nonresponsive CBS deficient patients, achieved by severe protein restriction and methionine-free amino acid supplements.
  • #2 Homocystinuria: MedlinePlus GeneticsLock
    https://medlineplus.gov/genetics/condition/homocystinuria/
    Homocystinuria is an inherited disorder in which the body is unable to process certain building blocks of proteins (amino acids) properly. […] Variants (also called mutations) in the CBS, MTHFR, MTR, MTRR, and MMADHC genes cause homocystinuria. […] Variants in the CBS gene cause classic homocystinuria. […] Rarely, homocystinuria can be caused by variants in several other genes. […] Researchers have not determined how excess homocysteine and related compounds lead to the signs and symptoms of homocystinuria.
  • #2 Homocystinuria – Wikipedia
    https://en.wikipedia.org/wiki/Homocystinuria
    Homocystinuria (HCU) is an inherited disorder of the metabolism of the amino acid methionine due to a deficiency of cystathionine beta synthase or methionine synthase. […] It is usually caused by the deficiency of the enzyme cystathionine beta synthase, mutations of other related enzymes such as methionine synthase, or the deficiency of folic acid, vitamin B12 and/or pyridoxine (vitamin B6).
  • #2 Homocystinuria/Homocysteinemia: Overview, Pathophysiology, Epidemiology
    https://emedicine.medscape.com/article/1115062-overview
    Homocystinuria is a disorder of methionine metabolism, leading to an abnormal accumulation of homocysteine and its metabolites (homocystine, homocysteine-cysteine complex, and others) in blood and urine. Homocystinuria is an autosomal recessively inherited defect in the transsulfuration pathway (homocystinuria I) or methylation pathway (homocystinuria II and III). […] Homocysteinemia may be due to a genetic predisposition to abnormal activity in the same pathways as homocystinuria. Nutritional and environmental factors, as well as specific medications, may worsen this abnormality and provoke symptoms. […] The accumulation of homocysteine and its metabolites is caused by disruption of any of the three interrelated pathways of methionine metabolismdeficiency in the cystathionine B-synthase (CBS) enzyme, defective methylcobalamin synthesis, or abnormality in methylene tetrahydrofolate reductase (MTHFR).
  • #2 Homocystinuria (HCU): Symptoms, Causes & Treatment
    https://my.clevelandclinic.org/health/diseases/25160-homocystinuria
    Homocystinuria is a genetic disorder that causes a buildup of homocysteine in your blood and urine. […] With homocystinuria, your body lacks an enzyme that it needs to metabolize homocysteine properly and keep it within a normal range. […] Genetic changes (mutations) in many different genes cause most types of homocystinuria. A mutation in the CBS gene causes the most common type of homocystinuria. […] Mutations in the MTHFR, MTR, MTRR and MMADHC genes can also cause homocystinuria. […] Homocystinuria can also occur due to non-genetic reasons. A severe lack of vitamin B6, vitamin B9 (folate) or vitamin B12 may cause the condition.
  • #2 Homocystinuria Information | Mount Sinai – New York
    https://www.mountsinai.org/health-library/diseases-conditions/homocystinuria
    Homocystinuria is inherited in families as an autosomal recessive trait. This means that the child must inherit a non-working copy of the gene from each parent to be seriously affected. […] Although no cure exists for homocystinuria, vitamin B therapy can help about half of people affected by the condition. […] Genetic counseling is recommended for people with a family history of homocystinuria who want to have children. Prenatal diagnosis of homocystinuria is available. This involves culturing amniotic cells or chorionic villi to test for cystathionine synthase (the enzyme that is missing in homocystinuria).
  • #2 SciELO Brazil – Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they Have in Common? Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they Have in Common?
    https://www.scielo.br/j/jiems/a/5KjZr63wC5Md7t3ZW5SpBhn/
    Genetic homocystinurias are a group of inborn errors of metabolism that result in the massive excretion of homocysteine (Hcy) in the urine due to Hcy accumulation in the body, usually causing neurological and cardiovascular complications. The three most frequent causes are classical homocystinuria [deficiency of cystathionine beta-synthase (CBS)], methylmalonic aciduria with homocystinuria, cblC type (cblC deficiency) and severe methylenetetrahydrofolate reductase (MTHFR) deficiency. […] Hyperhomocysteinemia (tHcy 15 M) can be caused by environmental (such as nutritional deficiency of vitamins B12 or folate) or genetic factors, including inborn errors of metabolism. […] The severe form of hyperhomocysteinemia (tHcy50 M) is rare, and typically associated with severe vitamin B12 or folate deficiency or inherited defects in Hcy metabolism.
  • #2 Homocystinuria due to cystathionine beta-synthase deficiency | MedLink Neurology
    https://www.medlink.com/articles/homocystinuria-due-to-cystathionine-beta-synthase-deficiency
    In addition to genetic etiologies, homocystinuria can also be caused by acquired forms of secondary to severe cobalamin (B12) deficiency. […] Homocystinuria is an autosomal recessive inherited disorder due to deficiency of cystathionine beta-synthase (EC 4.2.1.22, McKusick 236200). […] More than 320 individual homocystinuric alleles have been studied, and 100 mutations were detected. […] Deficiency of cystathionine beta-synthase leads to tissue accumulation of methionine, homocysteine, and their S-adenosyl derivatives, with lack of cystathionine and low levels of cysteine. […] The pathophysiology of cystathionine beta-synthase deficiency has not yet been completely elucidated, but accumulation of homocysteine probably plays a major role in determining some of the most relevant clinical manifestations, including generalized vascular damage and thromboembolic complications.
  • #2 Homocystinuria diagnosis and management: it is not all classical | Journal of Clinical Pathology
    https://jcp.bmj.com/content/75/11/744
    Homocystinuria (HCU) refers to a group of inherited disorders of homocysteine metabolism associated with high blood homocysteine concentration, thromboembolic tendency and neurocognitive symptoms. […] The most prevalent inherited disorder of homocysteine metabolism is classical HCU caused by deficiency of the pyridoxine-dependent enzyme, cystathione beta-synthase, which converts homocysteine to cystathionine in the transsulphuration pathway. […] Primary genetic disorders affecting function of CBS (classical HCU) or enzymes involved in remethylation impair metabolism of HCy causing it to rise in plasma from a reference concentration below 15 mol/L to at least 40 mol/L and usually over 100 mol/L. […] The most common causes of a high tHCy relate to underlying vitamin B12 or folate deficiency which is often first suspected when the CBC reveals a macrocytic anaemia.
  • #2 SciELO Brazil – Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they Have in Common? Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they Have in Common?
    https://www.scielo.br/j/jiems/a/5KjZr63wC5Md7t3ZW5SpBhn/
    This paper reviews the clinical and biochemical findings and management of the three most frequent genetic causes of homocystinurias: CBS deficiency or classical homocystinuria (HCU), methylmalonic aciduria with homocystinuria cblC type, and severe MTHFR deficiency. […] These three disorders all present with severe hyperhomocysteinemia, while Met levels are increased in HCU and decreased or normal in cblC and MTHFR deficiency, and methylmalonic acid (MMA) is increased only in cblC. […] In CBS deficient patients at diagnosis folate is often deficient likely due to the inhibition of MTHFR resulting in decreases of 5MTHF, the circulation form of folate. […] In MTHFR deficiency folate is severely deficient, whereas in cblC defect all folates accumulate as 5MTHF resulting in functional cellular folate deficiency.
  • #2 Homocystinuria – Child Neurology Foundation
    https://www.childneurologyfoundation.org/disorder/homocystinuria/
    There are other nongenetic causes of high homocysteine in the blood and urine. These causes are more common than genetic causes. They can have different signs and symptoms. Nongenetic causes can include: […] Vitamin deficiencies, particularly Vitamin B6 or Vitamin B12 deficiencies […] Low thyroid hormone levels […] Diabetes […] High cholesterol […] High blood pressure […] Medications, such as carbamazepine, phenytoin, atorvastatin, methotrexate […] Smoking […] Advanced age.
  • #2 Methionine Metabolism Disorders – Pediatrics – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pediatrics/inherited-disorders-of-metabolism/methionine-metabolism-disorders
    Homocysteine is an intermediate in methionine metabolism; it is either remethylated to regenerate methionine or combined with serine in a series of transsulfuration reactions to form cystathionine and then cysteine. […] Various defects in remethylation or transsulfuration can cause homocysteine to accumulate, resulting in disease. […] This disorder is caused by an autosomal recessive deficiency of cystathionine beta-synthase, which catalyzes cystathionine formation from homocysteine and serine. […] Homocysteine accumulates and dimerizes to form the disulfide homocystine, which is excreted in the urine. […] Because remethylation is intact, some of the additional homocysteine is converted to methionine, which accumulates in the blood. […] Excess homocysteine predisposes to thrombosis and has adverse effects on connective tissue (perhaps involving fibrillin), particularly the eyes and skeleton; adverse neurologic effects may be due to thrombosis or a direct effect.
  • #2 Homocystinuria due to cystathionine beta-synthase deficiency | MedLink Neurology
    https://www.medlink.com/articles/homocystinuria-due-to-cystathionine-beta-synthase-deficiency
    Thromboembolism has been suggested to be the end-point of homocysteine-induced abnormalities of platelets, endothelial cells, and coagulation factors. […] The risk for development of Alzheimer diseases is likely greater based on the observation that increased plasma homocysteine represents an independent risk factor.
  • #2 Homocystinuria | SpringerLink
    http://link.springer.com/10.1007/978-3-540-69000-9_505
    The term homocystinuria designates a biochemical abnormality, not a specific disease entity. There are many causes of homocystinuria. […] The most common defect, cystathionine -synthase (CBS) deficiency, results in high concentrations of serum methionine (Kaye and The Committee on Genetics 2006a, b). One form of CBS deficiency is responsive to vitamin B6. Other metabolic variants of homocystinuria include defects of Vitamin B12 uptake or activation and tetrahydrofolate reductase deficiency. […] Two mechanisms probably explain most of the clinical symptoms seen: Firstly abnormal (hyper) coagulation because of sticky platelets; and secondly direct toxicity of homocysteine and its metabolites, causing endothelial cell damage.
  • #2 Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency – GeneReviews® – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK1524/
    Homocystinuria caused by cystathionine -synthase (CBS) deficiency is characterized by involvement of the eye (ectopia lentis and/or severe myopia), skeletal system (excessive height, long limbs, scoliosis, and pectus excavatum), vascular system (thromboembolism), and CNS (developmental delay/intellectual disability). […] Classic homocystinuria is caused by deficiency of cystathionine -synthase (CBS), a pyridoxine (vitamin B6)-dependent enzyme. […] Homocystinuria is inherited in an autosomal recessive manner. […] The two phenotypic variants of classic homocystinuria are B6-responsive and B6-non-responsive homocystinuria. B6-responsive homocystinuria is typically (but not always) milder than the non-responsive variant. […] „Homocystinuria” was named for excess homocystine in the urine, though now it is primarily detected by increased total homocysteine in plasma. Homocystinuria may be caused by genetically determined deficient activity of cystathionine -synthase (CBS), or a variety of genetic problems that ultimately interfere with conversion of homocysteine to methionine. […] Non-genetically determined severe dietary lack of cobalamin (vitamin B12 deficiency) may also cause „homocystinuria”.
  • #2 Homocystinuria diagnosis and management: it is not all classical | Journal of Clinical Pathology
    https://jcp.bmj.com/content/75/11/744
    In a minority of cases serum B12 and folate results may not reflect whole body deficits and if deficiency is suspected, confirmatory tests are indicated. […] Once secondary causes are excluded, measurement of other amino acids in the HCy metabolic pathway, notably methionine and cystine, with quantitation of MMA in plasma or urine helps to distinguish between the genetic conditions of classical HCU and remethylation defects caused by MTHF reductase (MTHFR) or a disorder of cobalamin metabolism. […] HCU caused by CBS deficiency is the most common condition of hyperhomocystinaemia. […] Thromboembolic tendency increases in direct proportion to the magnitude and duration of HCy elevation. […] The CBS enzyme uses pyridoxal 5-phosphate as a cofactor. Approximately 50% of patients with HCU respond partially or wholly to high-dose pyridoxine (vitamin B6).
  • #2 Homocystinuria, Beta-Synthase Deficiency | Hereditary Ocular Diseases
    https://disorders.eyes.arizona.edu/disorders/homocystinuria-beta-synthase-deficiency
    Classic homocystinuria is an autosomal recessive disorder that results from mutations in the CBS (21q22.3) gene encoding cystathionine beta-synthase. […] Numerous mutations have been identified but among the most common ones are I278T which causes a pyridoxine-responsive disorder, and the G3307S mutation which leads to a variant that is not responsive to pyridoxine treatment. […] Homocystinuria may result from a mutation in in the CBS gene.
  • #2 CBS (homocystinemia/cystathionine beta-synthase deficiency) – newbornscreening.info
    https://www.newbornscreening.info/cbs-homocystinemia-cystathionine-beta-synthase-deficiency/
    When both parents are carriers, there is a 25% chance in each pregnancy for the child to have homocystinuria. […] About one in every 200,000 to 300,000 babies in the United States is born with homocystinuria. […] This condition occurs in all ethnic groups around the world. It is found more often in white people from the New England region of the United States. It is also more common in people with Irish ancestry.
  • #2 Homocystinuria | Amino Acid Metabolism Disorder – Causes, Symptoms, Diagnosis and Treatment
    https://www.medindia.net/health/conditions/homocystinuria-amino-acid-metabolism-disorder.htm
    When CBS is deficient, homocysteine accumulates in the tissues along with its precursor amino acid methionine. […] High levels of homocysteine mainly affect supporting connective tissue in different parts of the body. […] The build-up of homocysteine also damages the supporting tissue of the body’s skeleton, and damages the connective tissue in the walls of blood vessels. […] Diagnosis is suspected during clinical examination and based on clinical suspicion diagnosis is confirmed by blood tests, imaging tests and skin biopsy. […] Genetic testing can be done to look for presence of the abnormal gene. […] It is difficult to prevent homocystinuria as this disorder occurs due to genetic mutations. […] Complications of homocystinuria may be prevented by screening of newborns with a blood test around five days within birth to check for the condition so that early treatment can be started.
  • #2 Homocystinuria due to cystathionine beta-synthase deficiency | MedLink Neurology
    https://www.medlink.com/articles/homocystinuria-due-to-cystathionine-beta-synthase-deficiency
    Dislocation of the optic lens, osteoporosis, thinning and lengthening of the long bones, intellectual disability, and thromboembolism are the most common features in homocystinuria due to cystathionine beta-synthase deficiency. […] There are multiple causes for homocystinuria. […] Homocystinuria is a rare inborn error of metabolism caused by mutations in the cystathionine beta-synthase gene. […] There are 2 major types of homocystinuria due to cystathionine beta-synthase deficiency based on their response to B6 (pyridoxine). […] Homocystinuria due to cystathionine beta-synthase deficiency is screened for in some newborn screening programs. […] Homocystinuria presents with elevated urinary homocysteine and plasma homocysteine. There are multiple causes that include genetic forms of inborn errors of metabolism related to interference with conversion of homocysteine to methionine and abnormalities of cobalamin transport or metabolism.
  • #2 Homocystinuria – UF Health
    https://ufhealth.org/conditions-and-treatments/homocystinuria
    Homocystinuria is inherited in families as an autosomal recessive trait. This means that the child must inherit a non-working copy of the gene from each parent to be seriously affected. […] Genetic counseling is recommended for people with a family history of homocystinuria who want to have children. Prenatal diagnosis of homocystinuria is available. This involves culturing amniotic cells or chorionic villi to test for cystathionine synthase (the enzyme that is missing in homocystinuria). […] If there are known gene defects in the parents or family, samples from chorionic villus sampling or amniocentesis can be used to test for these defects.
  • #2
    https://myhealth.alberta.ca/Health/pages/conditions.aspx?hwid=tu2113
    Homocystinuria is a rare inherited disease that causes a deficiency of one of several enzymes needed for the breakdown of food (metabolism). […] This enzyme deficiency may cause a buildup of homocysteine in the blood. […] Excess homocysteine may be released in the urine. […] People with homocystinuria may develop diseases of the heart and blood vessels at a young age. […] If homocystinuria is not diagnosed in infancy, other problems may develop, including: […] Formation of blood clots in deep veins (deep venous thrombosis, or DVT). […] Stroke.
  • #2
    https://www.omim.org/entry/236200
    A number sign (#) is used with this entry because homocystinuria with or without response to pyridoxine is caused by homozygous or compound heterozygous mutation in the gene encoding cystathionine beta-synthase (CBS; 613381) on chromosome 21q22. […] Classic homocystinuria is an autosomal recessive metabolic disorder of sulfur metabolism. […] The clinical features of untreated homocystinuria due to CBS deficiency usually manifest in the first or second decade of life and include myopia, ectopia lentis, mental retardation, skeletal anomalies resembling Marfan syndrome (MFS; 154700), and thromboembolic events. […] There are 2 main phenotypes of the classic disorder: a milder pyridoxine (vitamin B6)-responsive form, and a more severe pyridoxine-nonresponsive form. […] Some patients have been reported to have a milder form of homocystinuria, which is characterized by increased plasma homocysteine and increased risk for thrombotic events in young adulthood, but without the other skeletal, ocular, or nervous system manifestations observed in classic homocystinuria.
  • #2 Orphanet: Homocystinuria due to cystathionine beta-synthase deficiency
    https://www.orpha.net/en/disease/detail/394
    A rare metabolic disease of methionine catabolism characterized by accumulation of methionine and homocysteine with clinical involvement of the eye, skeletal system, vascular system and central nervous system (CNS). […] The disease is caused by mutations in the CBS gene (21q22.3) leading to the accumulation of homocysteine and methionine, which are toxic for the endothelium, and causes neurocognitive impairment. […] Cysteine deficiency probably plays a role in connective tissue abnormalities, including lens dislocation.
  • #2 Newborn screening information for homocystinuria | Baby’s First Test | Newborn Screening | Baby Health
    https://www.babysfirsttest.org/newborn-screening/conditions/homocystinuria
    Homocystinuria (HCY) is a condition in which the body is unable to break down certain proteins. […] In homocystinuria (HCY), the enzymes that break down the amino acids methionine and homocysteine are not working correctly. […] In most cases of HCY, the enzyme cystathionine beta-synthase (CBS) is not working. After methionine is broken down into homocysteine, CBS helps to break down homocysteine. […] If your babys body has non-working copies of CBS, then homocysteine cannot be broken down. This causes high levels of methionine and homocysteine to build up in the body. […] HCY is an autosomal recessive genetic condition. This means that a child must inherit two copies of the non-working gene for HCY, one from each parent, in order to have the condition. The parents of a child with an autosomal recessive condition each carry one copy of the non-working gene, but they typically do not show signs and symptoms of the condition.
  • #2 Homocystinuria | PPT
    https://www.slideshare.net/slideshow/homocystinuria-238455286/238455286
    Other causes Homocystinuria Caused by Defects in Methylcobalamin Formation Homocystinuria Caused by Deficiency of Methylene tetrahydrofolate Reductase. […] Homocystinuria Caused by Defects in Methylcobalamin Formation Methylcobalamin is the cofactor for the enzyme methionine synthase, which catalyzes remethylation of homocysteine to methionine. […] Homocystinuria is a disorder of methionine metabolism caused by an inability to metabolize homocysteine. […] There are three main types: classic homocystinuria caused by cystathionine -synthase deficiency; defects in methylcobalamin formation; and methylenetetrahydrofolate reductase deficiency.
  • #2 Methionine Metabolism Disorders – Pediatrics – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pediatrics/inherited-disorders-of-metabolism/methionine-metabolism-disorders
    Various defects in the remethylation process can result in homocystinuria. […] Defects include deficiencies of methionine synthase (MS) and MS reductase (MSR), delivery of methylcobalamin and adenosylcobalamin, and deficiency of methylenetetrahydrofolate reductase (MTHFR, which is required to generate the 5-methyltetrahydrofolate needed for the MS reaction). […] Because there is no methionine elevation in these forms of homocystinuria, they are not detected by neonatal screening.
  • #2 WV DHHR – OMCFH – Newborn Metabolic Screening – Homocystinuria
    https://www.wvdhhr.org/nbms/diseases/Homocystinuria.asp
    Treatment depends on the underlying cause of homocystinuria. As a first step, pyridoxine (vitamin B6) responsiveness should be ascertained, because approximately 50% of patients respond to large doses of this vitamin. Nonresponsive patients with CBS deficiency should be treated with a methionine-restricted, cystine-supplemented diet. Folic acid and betaine therapy may also be helpful with all patients. In the disorders of cobalamin metabolism and transport in which methylmalonic acid and homocystine appear in the urine, hydroxycobalamin treatment (vitamin B12, not cyanocobalamin) may be beneficial.
  • #2 Homocystinuria: Causes, symptoms, and tests
    https://www.medicalnewstoday.com/articles/318526
    Homocystinuria is a genetic disorder in which the body cannot break down a particular amino acid. […] The disorder passes from parents to children in an autosomal recessive manner, which means that two copies of an irregular gene must be present for it to develop. […] As homocystinuria is genetically autosomal recessive, a child must inherit a copy of the mutated gene for homocystinuria from each parent to develop the condition. […] Parents who carry just one mutated gene may not have any symptoms of homocystinuria. […] According to researchers, the child of parents who both are carriers of the gene has a 25% chance of having homocystinuria. […] The most common form of homocystinuria is called cystathionine beta-synthase (CBS). […] There is no cure for homocystinuria. However, it is possible to manage the condition with dietary restrictions, supplements, and medication. […] The only reason for genetic testing is to give people an idea of their risk of passing on a gene mutation that can lead to homocystinuria.
  • #2 HIE Multimedia – Homocystinuria
    https://adamcertificationdemo.adam.com/content.aspx?productid=117&pid=1&gid=001199
    Homocystinuria is inherited in families as an autosomal recessive trait. This means that the child must inherit a non-working copy of the gene from each parent to be seriously affected. […] Genetic counseling is recommended for people with a family history of homocystinuria who want to have children. Prenatal diagnosis of homocystinuria is available. This involves culturing amniotic cells or chorionic villi to test for cystathionine synthase (the enzyme that is missing in homocystinuria).
  • #3
    https://www.omim.org/entry/236200
    A number sign (#) is used with this entry because homocystinuria with or without response to pyridoxine is caused by homozygous or compound heterozygous mutation in the gene encoding cystathionine beta-synthase (CBS; 613381) on chromosome 21q22. […] Classic homocystinuria is an autosomal recessive metabolic disorder of sulfur metabolism. […] The clinical features of untreated homocystinuria due to CBS deficiency usually manifest in the first or second decade of life and include myopia, ectopia lentis, mental retardation, skeletal anomalies resembling Marfan syndrome (MFS; 154700), and thromboembolic events. […] There are 2 main phenotypes of the classic disorder: a milder pyridoxine (vitamin B6)-responsive form, and a more severe pyridoxine-nonresponsive form. […] Some patients have been reported to have a milder form of homocystinuria, which is characterized by increased plasma homocysteine and increased risk for thrombotic events in young adulthood, but without the other skeletal, ocular, or nervous system manifestations observed in classic homocystinuria.
  • #3 Homocystinuria – Children’s Health Issues – Merck Manual Consumer Version
    https://www.merckmanuals.com/home/children-s-health-issues/hereditary-metabolic-disorders/homocystinuria
    Homocystinuria is a disorder of amino acid metabolism that is caused by a lack of the enzyme cystathionine beta-synthase, which is needed to metabolize the amino acid homocysteine. […] Homocystinuria is caused by a lack of the enzyme needed to metabolize homocysteine. […] Homocystinuria occurs when parents pass on to their children the defective genes that cause this disorder. […] In homocystinuria, both parents of the affected child carry 1 copy of the abnormal gene. Because usually 2 copies of the abnormal (recessive) gene are necessary for the disorder to occur, usually neither parent has the disorder.